Craig-Hallum upgraded TerrAscend to Buy from Hold with a $2.25 price target. The company’s “impressive” capital raises alleviate the balance sheet overhang and justify a premium valuation, the analyst tells investors in a research note. The firm sees TerrAscend’s momentum continuing despite the year-to-date share rally.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TRSSF:
- TerrAscend Increases Footprint in Maryland to Four Dispensaries with Agreement to Acquire Herbiculture, Transaction Already Approved by Maryland Regulator
- TerrAscend Closes on Third Dispensary Acquisition in Maryland Ahead of Adult-Use Launch
- Here’s What You Missed in Cannabis This Week
- TerrAscend Declares its Independence
- TerrAscend to commence trading on Toronto Stock Exchange
